Projects per year
My research expertise is in the area of geriatric pharmacoepidemiology. Pharmacoepidemiology employs the methods of epidemiology to study outcomes of drug treatments in specific populations in real-world settings. The group has collaborations with centres in Christchurch (Big Data and Better Ageing Research Group, University of Otago, Christchurch) and researchers based at The University of Sydney, University of Queensland, Monash University & Yale University. The research group also has collaborations and support from The Ministry of Health, New Zealand. The group positioned along the translational axis delivers high-quality research that has a considerable impact on medicines policy and practice.
I am interested to recruit doctoral students. Current projects on offer:
1. Development and validation of a novel anticholinergic tool to quantify anticholinergic burden.
2. Novel pharmacoepidemiological approaches to predict adverse drug reactions.
3. Measuring the impact of drug burden and polypharmacy on health outcomes in older people.
4. Deprescribing medicines with limited time-until-benefit in older people.
5. Measuring the impact of the anticholinergic burden on health outcomes in individuals with dementia.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Pharmacy, Doctor of Philosophy, University of Sydney
Award Date: 18 Dec 2009
Senior Research Fellow, University of Otago
9 Oct 2018 → …
- RM Therapeutics. Pharmacology
- RS Pharmacy and materia medica
- 1 Similar Profiles
Dive into details
Select a country/territory to view shared publications and projects
Development of a digital therapeutic intervention to improve the quality of life and reduce the healthcare costs of those living with chronic diseases
1/09/22 → 28/02/23
Project: Research-related funding
Artificial intelligence for identifying new disease clusters in patients with immune-mediated inflammatory conditions: A Proof-of-Concept Study
4/01/21 → 31/12/21
Project: Central government, health and local authorities
Examining risks of bleeding and cardiovascular events in older people using anticoagulant and antiplatelet therapy
1/01/15 → 31/12/15
Project: Project at a former HEI
Analysis of the adverse nervous system and gastrointestinal events associated with solifenacin in older adults using the US FDA adverse event reporting systemNicholls, C., Chyou, T. & Nishtala, P. S., 21 Apr 2022, In: International Journal of Risk & Safety in Medicine. p. 1-11 11 p.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile4 Downloads (Pure)
Antibacterial‐associated acute kidney injury among older adults: A post‐marketing surveillance study using the FDA Adverse Events Reporting SystemChinzowu, T., Chyou, T. & Nishtala, P. S., 7 Jun 2022, (E-pub ahead of print) In: Pharmacoepidemiology and Drug Safety.
Research output: Contribution to journal › Article › peer-reviewOpen AccessFile3 Downloads (Pure)
Antimicrobial-associated organ injury among the elderly: A systematic review and meta-analysis protocolChinzowu, T., Roy, S. & Nishtala, P., 11 Feb 2022, In: BMJ Open. 12, 2, e055210.
Research output: Contribution to journal › Article › peer-reviewOpen Access
An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019Nishtala, P. S. & Chyou, T., 13 Jul 2022, (E-pub ahead of print) In: Drugs & Aging.
Research output: Contribution to journal › Article › peer-review
ARTIFICIAL INTELLIGENCE FOR IDENTIFYING NEW DISEASE CLUSTERS IN PATIENTS WITH PSORIATIC ARTHRITIS/PSORIASIS: A PROOF-OF-CONCEPT STUDYNishtala, P., 23 May 2022, In: Annals of the Rheumatic Diseases. 2022, 81, p. 1047-1048 2 p.
Research output: Contribution to journal › Meeting abstract › peer-reviewOpen AccessFile1 Downloads (Pure)